EntryPoint Capital’s Agilon Health AGL Stock Holding History

EntryPoint Capital’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,034	Closed	-$59.4K	–	653
2025 Q2	$59.4K	Sell	1,034 -3,740	-78%	-$300K	0.03%	585
2025 Q1	$517K	Sell	4,774 -4,549	-49%	-$396K	0.24%	94
2024 Q4	$443K	Buy	9,323 +6,842	+276%	+$414K	0.19%	157
2024 Q3	$244K	Buy	+2,481	New	+$320K	0.14%	351

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NPCM

North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

EntryPoint Capital's AGL Position: Q3 2025 in Review

EntryPoint Capital sold out of Agilon Health (AGL) in Q3 2025, closing a stake of 1,034 shares — an estimated $59.4K sold.

EntryPoint Capital first reported a position in AGL in Q3 2024 and held it in 4 quarters. The position peaked at $517K in Q1 2025. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

EntryPoint Capital reported no remaining Agilon Health position as of Q3 2025 after selling out during the quarter.
EntryPoint Capital sold 1,034 Agilon Health shares in Q3 2025, an estimated $59.4K.
EntryPoint Capital first reported a position in Agilon Health in Q3 2024 and held it in 4 quarters.
EntryPoint Capital's Agilon Health position peaked at $517K in Q1 2025.
190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on EntryPoint Capital's 13F filing for Q3 2025, filed 13 Nov 2025.